Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+15.82%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12.2B
Cap. Flow
% of AUM
-42.5%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,004
Reduced
446
Closed
86
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$69.1M |
| 2 |
iShares S&P 100 ETF
OEF
|
$58.9M |
| 3 |
iShares MBS ETF
MBB
|
$58.1M |
| 4 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
$58.1M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$34.2M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$4.12B |
| 2 |
MakeMyTrip
MMYT
|
$2.34B |
| 3 |
Trip.com Group
TCOM
|
$752M |
| 4 |
Yum China
YUMC
|
$508M |
| 5 |
Alibaba
BABA
|
$457M |
Sector Composition
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Galapagos
GLPG
$2.2B
| $16K | ﹤0.01% |
572
+83
| +17% | +$2.32K |
|
1427
Regenxbio
RGNX
$490M
| $15.9K | ﹤0.01% |
1,938
+307
| +19% | +$2.52K |
|
1428
Tourmaline Bio
TRML
$687M
| $15.9K | ﹤0.01% |
992
+113
| +13% | +$1.81K |
|
|
NXRT
1429
NexPoint Residential Trust
NXRT
$879M
| $15.9K | ﹤0.01% |
476
-142
| -23% | -$4.73K |
|
1430
TriNet
TNET
$3.43B
| $15.8K | ﹤0.01% |
+216
| New | +$15.8K |
|
1431
ACI Worldwide
ACIW
$5.12B
| $15.6K | ﹤0.01% |
340
-18,261
| -98% | -$838K |
|
|
BDN
1432
Brandywine Realty Trust
BDN
$759M
| $15.4K | ﹤0.01% |
3,584
-1,080
| -23% | -$4.63K |
|
1433
Savara
SVRA
$643M
| $15.2K | ﹤0.01% |
6,677
+934
| +16% | +$2.13K |
|
1434
IAC Inc
IAC
$2.98B
| $15.2K | ﹤0.01% |
+406
| New | +$15.2K |
|
1435
Aaon
AAON
$6.64B
| $15K | ﹤0.01% |
204
+1
| +0.5% | +$74 |
|
|
SAFE
1436
Safehold
SAFE
$1.17B
| $15K | ﹤0.01% |
966
-288
| -23% | -$4.48K |
|
1437
Aura Biosciences
AURA
$403M
| $15K | ﹤0.01% |
2,395
+739
| +45% | +$4.63K |
|
1438
ManpowerGroup
MAN
$1.91B
| $14.9K | ﹤0.01% |
+370
| New | +$14.9K |
|
|
ITOS
1439
DELISTED
iTeos Therapeutics
ITOS
| $14.7K | ﹤0.01% |
1,479
+257
| +21% | +$2.56K |
|
1440
Solid Biosciences
SLDB
$428M
| $14.6K | ﹤0.01% |
2,994
+504
| +20% | +$2.46K |
|
1441
StoneCo
STNE
$4.63B
| $14.4K | ﹤0.01% |
897
-8,504
| -90% | -$136K |
|
1442
Pacific Biosciences
PACB
$381M
| $14.4K | ﹤0.01% |
11,592
+2,355
| +25% | +$2.92K |
|
|
TECX
1443
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $14.3K | ﹤0.01% |
721
+221
| +44% | +$4.39K |
|
1444
Erasca
ERAS
$457M
| $13.9K | ﹤0.01% |
10,943
+1,483
| +16% | +$1.88K |
|
1445
SAP
SAP
$313B
| $13.7K | ﹤0.01% |
45
-16,598
| -100% | -$5.05M |
|
1446
Arcturus Therapeutics
ARCT
$485M
| $13.6K | ﹤0.01% |
1,048
+142
| +16% | +$1.85K |
|
|
PLYM
1447
Plymouth Industrial REIT
PLYM
$998M
| $13.6K | ﹤0.01% |
849
-254
| -23% | -$4.08K |
|
1448
Steven Madden
SHOO
$2.2B
| $13.6K | ﹤0.01% |
568
+128
| +29% | +$3.07K |
|
|
GOOD
1449
Gladstone Commercial Corp
GOOD
$616M
| $13.6K | ﹤0.01% |
948
-238
| -20% | -$3.41K |
|
1450
Maravai LifeSciences
MRVI
$363M
| $13.4K | ﹤0.01% |
5,562
+874
| +19% | +$2.11K |
|